Evidence map›Paper›PMID 41279591›Full record

ArticlebioRxiv : the preprint server for biology2025

Compensatory tRNA Modification by DUS3L Confers Resistance to METTL1 Loss in Oesophageal Cancer.

Helena Santos-Rosa, Jonathan L Price, Georgia Tsagkogeorga, Alexandra Sapetschnig, Bianca Pierattini, David Jordan, Paula Milan-Rois, Almudena Serrano-Benitez, Katherine Stott, Namshik Han and 2 more

Abstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Helena Santos-RosaDepartment of Biochemistry, University of Cambridge, 80 Tennis Court Road, Cambridge CB2 1GA, UK.
Jonathan L PriceDepartment of Biochemistry, University of Cambridge, 80 Tennis Court Road, Cambridge CB2 1GA, UK.
Georgia TsagkogeorgaMilner Therapeutics Institute, University of Cambridge, Cambridge CB2 0AW, UK.
Alexandra SapetschnigGurdon Institute, University of Cambridge, Tennis Court Road, Cambridge CB2 1QN, UK.
Bianca PierattiniDepartment of Biochemistry, University of Cambridge, 80 Tennis Court Road, Cambridge CB2 1GA, UK.
David JordanDepartment of Biochemistry, University of Cambridge, 80 Tennis Court Road, Cambridge CB2 1GA, UK.
Paula Milan-RoisDepartment of Biochemistry, University of Cambridge, 80 Tennis Court Road, Cambridge CB2 1GA, UK.
Almudena Serrano-BenitezGurdon Institute, University of Cambridge, Tennis Court Road, Cambridge CB2 1QN, UK.
Katherine StottDepartment of Biochemistry, University of Cambridge, 80 Tennis Court Road, Cambridge CB2 1GA, UK.
Namshik HanMilner Therapeutics Institute, University of Cambridge, Cambridge CB2 0AW, UK.
Tony KouzaridesGurdon Institute, University of Cambridge, Tennis Court Road, Cambridge CB2 1QN, UK.
Eric A MiskaDepartment of Biochemistry, University of Cambridge, 80 Tennis Court Road, Cambridge CB2 1GA, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

tRNA N

Identifiers

PMID41279591
PMCPMC12632823

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.